Insmed Inc (NASDAQ:INSM) - Share price - Overview

Stock Report

Insmed Inc INSM

Last Price
$28.47

Day Change
0.34|1.21%

As of 18/05/2018
17:09:30 EDT | USD
Minimum 15 Minutes Delay.

Last Close28.13
Day Range27.20 - 28.62
Mkt Cap2.18Bil
52-Wk Range11.49 - 33.94
Yield %-
ISINUS4576693075
Volume838,253
P/E-8.95
P/SInfinity
P/CF-10.48

Share Price

Financials
201520162017
More ...
Income Statement
Revenue0.000.000.00
Operating Income-117.49-173.40-188.92
Net Income-118.18-176.27-192.65
Basic EPS-2.02-2.85-2.89
Avg. Diluted Shares Outstanding596267
Balance Sheet
Current Assets288.12168.41389.44
Non Current Assets68.4469.5572.60
Total Assets356.56237.96462.05
Current Liabilities22.2627.9944.66
Total Liabilities---
Total Equity311.70154.48361.06
Cash Flow
Operating Cash Flow-100.70-146.71-159.62
Capital Expenditure-3.45-4.20-3.00
Free Cash Flow-104.15-150.91-162.62

In millions, except "Basic EPS". Currency is USD.

Company Profile

Insmed Inc is a global biotechnology company. It is focused on developing novel therapies that focus primarily on lung diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

214
Key Stats
More ...
Price/Earning TTM-8.85
Price/Book4.96
Price/Sales TTMInfinity
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % TTM-Infinity
Net Margin % TTM-Infinity
ROE TTM-74.74
Debt/Equity0.15
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.